Citations (136)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Nam Hoon Kwon, Mi Ran Lee, Jiwon Kong, Seung Kyun Park, Byung Joon Hwang, Byung Gyu Kim, Eun-Shin Lee, Hyeong-Gon Moon & Sunghoon Kim. (2018) Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signaling for cell proliferation. RNA Biology 15:4-5, pages 635-648.
Read now
Read now
Leticia Labriola, Mariana Salatino, Cecilia J. Proietti, Adalí Pecci, Omar A. Coso, Alberto R. Kornblihtt, Eduardo H. Charreau & Patricia V. Elizalde. (2003) Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells. Molecular and Cellular Biology 23:3, pages 1095-1111.
Read now
Read now
Tadahiro Kitamura, Yoshiaki Kido, Serge Nef, Jussi Merenmies, Luis F. Parada & Domenico Accili. (2001) Preserved Pancreatic β-Cell Development and Function in Mice Lacking the Insulin Receptor-Related Receptor. Molecular and Cellular Biology 21:16, pages 5624-5630.
Read now
Read now
Carolyn I. Sartor, Hong Zhou, Ewa Kozlowska, Katherine Guttridge, Evelyn Kawata, Laura Caskey, Jennifer Harrelson, Nancy Hynes, Stephen Ethier, Benjamin Calvo & H. Shelton Earp$suffix/text()$suffix/text(). (2001) HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells. Molecular and Cellular Biology 21:13, pages 4265-4275.
Read now
Read now
Heidi A. Lane, Iwan Beuvink, Andrea B. Motoyama, John M. Daly, Richard M. Neve & Nancy E. Hynes. (2000) ErbB2 Potentiates Breast Tumor Proliferation through Modulation of p27Kip1-Cdk2 Complex Formation: Receptor Overexpression Does Not Determine Growth Dependency. Molecular and Cellular Biology 20:9, pages 3210-3223.
Read now
Read now
Senthil K. Muthuswamy, Michael Gilman & Joan S. Brugge. (1999) Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers. Molecular and Cellular Biology 19:10, pages 6845-6857.
Read now
Read now
Phyllis L. Osheroff, Siao Ping Tsai, Nancy Y. Chiang, Kathleen L. King, Ronghao Li, Gail D. Lewis, Kenneth Wong, William Henzel & Jennie Mather. (1999) Receptor Binding and Biological Activity of Mammalian Expressed Sensory and Motor Neuron-derived Factor (SMDF). Growth Factors 16:3, pages 241-253.
Read now
Read now
Monilola A. Olayioye, Diana Graus-Porta, Roger R. Beerli, Jack Rohrer, Brigitte Gay & Nancy E. Hynes. (1998) ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner. Molecular and Cellular Biology 18:9, pages 5042-5051.
Read now
Read now
Jianping Ye, Ruo Hui Xu, Joyce Taylor-Papadimitriou & Paula M. Pitha. (1996) Sp1 Binding Plays a Critical Role in Erb-B2- and v-ras-Mediated Downregulation of α2-Integrin Expression in Human Mammary Epithelial Cells. Molecular and Cellular Biology 16:11, pages 6178-6189.
Read now
Read now
Articles from other publishers (127)
Zahra Motamedi, Mehri Shahsavari, Hassan Rajabi-Maham & Maryam Azimzadeh Irani. (2022) Cancer regulator EGFR-ErbB4 heterodimer is stabilized through glycans at the dimeric interface. Journal of Molecular Modeling 28:12.
Crossref
Crossref
Lauren M. Lucas, Vipasha Dwivedi, Jared I. Senfeld, Richard L. Cullum, Christopher P. Mill, J. Tyler Piazza, Ianthe N. Bryant, Laura J. Cook, S. Tyler Miller, James H. LottIVIV, Connor M. Kelley, Elizabeth L. Knerr, Jessica A. Markham, David P. Kaufmann, Megan A. Jacobi, Jianzhong Shen & David J. RieseIIII. (2022) The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Pharmacological Reviews 74:1, pages 18-47.
Crossref
Crossref
Zahra Motamedi, Hassan Rajabi-Maham & Maryam Azimzadeh Irani. (2021) Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation — molecular dynamics study. Journal of Molecular Modeling 27:12.
Crossref
Crossref
Shazia Bano, Girgis Obaid, Joseph W. R. Swain, Marina Yamada, Brian W. Pogue, Kenneth Wang & Tayyaba Hasan. (2020) NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer. Journal of Clinical Medicine 9:8, pages 2390.
Crossref
Crossref
Pravin TP Kaumaya. (2020) B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine. Future Oncology.
Crossref
Crossref
Sabrina A. Maisel, Derrick Broka, Benjamin Atwell, Thomas Bunch, Robert Kupp, Shiv K. Singh, Shwetal Mehta & Joyce Schroeder. (2019) Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer. Journal of Translational Medicine 17:1.
Crossref
Crossref
Girgis Obaid, Shazia Bano, Srivalleesha Mallidi, Mans Broekgaarden, Jerrin Kuriakose, Zachary Silber, Anne-Laure Bulin, Yucheng Wang, Zhiming Mai, Wendong Jin, Diane Simeone & Tayyaba Hasan. (2019)
Impacting Pancreatic Cancer Therapy in Heterotypic
in Vitro
Organoids and
in Vivo
Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?
. Nano Letters 19:11, pages 7573-7587.
Crossref
Crossref
Kelly E. McCann & Dennis J. Slamon. 2019. Her2-Positive Breast Cancer. Her2-Positive Breast Cancer
1
11
.
Xiangfeng Qin, Cheng Ye, Xiaoyun Zhou, Jingyi Jia, Shaohua Xu, Qiongyao Hu & Guangfu Hu. (2018) NK3R Mediates the EGF-Induced SLα Secretion and mRNA Expression in Grass Carp Pituitary. International Journal of Molecular Sciences 20:1, pages 91.
Crossref
Crossref
Jenny Worthington, Georgia Spain & John F. Timms. (2017) Effects of ErbB2 Overexpression on the Proteome and ErbB Ligand-specific Phosphosignaling in Mammary Luminal Epithelial Cells. Molecular & Cellular Proteomics 16:4, pages 608-621.
Crossref
Crossref
P.T.P. Kaumaya & T. Bekaii-Saab. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
1
31
.
Stephen E.D. Webb, Michael Hirsch, Sarah R. Needham, Benjamin C. Coles, Kathrin M. Scherer, Selene K. Roberts, Laura C. Zanetti-Domingues, Christopher J. Tynan, Marisa L. Martin-Fernandez & Daniel J. Rolfe. (2015) Nanometric molecular separation measurements by single molecule photobleaching. Methods 88, pages 76-80.
Crossref
Crossref
Shi Hu, Yuna Sun, Yanchun Meng, Xiaoze Wang, Weili Yang, Wenyan Fu, Huaizu Guo, Weizhu Qian, Sheng Hou, Bohua Li, Zihe Rao, Zhiyong Lou & Yajun Guo. (2015) Molecular architecture of the ErbB2 extracellular domain homodimer. Oncotarget 6:3, pages 1695-1706.
Crossref
Crossref
Warut Tulalamba, Noppadol Larbcharoensub & Tavan Janvilisri. (2014) ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma. Journal of Clinical Pathology 67:8, pages 667-672.
Crossref
Crossref
Ilkka Paatero, Tiffany N. Seagroves, Katri Vaparanta, Wen Han, Frank E. Jones, Randall S. Johnson & Klaus Elenius. (2014) Hypoxia-inducible Factor-1α Induces ErbB4 Signaling in the Differentiating Mammary Gland. Journal of Biological Chemistry 289:32, pages 22459-22469.
Crossref
Crossref
Anna-Maria Stock, Stephan A Hahn, Gabriele Troost, Bernd Niggemann, Kurt S Zänker & Frank Entschladen. (2014) Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation. Experimental Cell Research 326:2, pages 307-314.
Crossref
Crossref
Arjan Kol, Anton G.T. Terwisscha van Scheltinga, Hetty Timmer-Bosscha, Laetitia E. Lamberts, Frederike Bensch, Elisabeth G.E. de Vries & Carolina P. Schröder. (2014) HER3, serious partner in crime. Pharmacology & Therapeutics 143:1, pages 1-11.
Crossref
Crossref
D Wetterskog, K-K Shiu, I Chong, T Meijer, A Mackay, M Lambros, D Cunningham, J S Reis-Filho, C J Lord & A Ashworth. (2013) Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers. Oncogene 33:8, pages 966-976.
Crossref
Crossref
Sarah R. NeedhamLaura C. Zanetti-DominguesMichael HirschDaniel J. RolfeChristopher J. TynanSelene K. RobertsMarisa L. Martin-FernandezDavid T. Clarke. (2014) Structure–function relationships and supramolecular organization of the EGFR (epidermal growth factor receptor) on the cell surface. Biochemical Society Transactions 42:1, pages 114-119.
Crossref
Crossref
Sarah R. Needham, Michael Hirsch, Daniel J. Rolfe, David T. Clarke, Laura C. Zanetti-Domingues, Richard Wareham & Marisa L. Martin-Fernandez. (2013) Measuring EGFR Separations on Cells with ∼10 nm Resolution via Fluorophore Localization Imaging with Photobleaching. PLoS ONE 8:5, pages e62331.
Crossref
Crossref
Pravin TP KaumayaKevin Chu Foy. (2012) Peptide vaccines and peptidomimetics targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncology 8:8, pages 961-987.
Crossref
Crossref
Jason A Wilken, Tayf Badri, Sarah Cross, Rhoda Raji, Alessandro D Santin, Peter Schwartz, Adam J Branscum, Andre T Baron, Adam I Sakhitab & Nita J Maihle. (2012) EGFR/HER-targeted therapeutics in ovarian cancer. Future Medicinal Chemistry 4:4, pages 447-469.
Crossref
Crossref
Nadezhda N. Zheleznova, Patricia D. Wilson & Alexander Staruschenko. (2011) Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:10, pages 1301-1313.
Crossref
Crossref
Sylwia Ammoun & C. Oliver Hanemann. (2011) Emerging therapeutic targets in schwannomas and other merlin-deficient tumors. Nature Reviews Neurology 7:7, pages 392-399.
Crossref
Crossref
Kevin C. Foy, Zhenzhen Liu, Gary Phillips, Megan Miller & Pravin T.P. Kaumaya. (2011) Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responses in Vitro and in Vivo. Journal of Biological Chemistry 286:15, pages 13626-13637.
Crossref
Crossref
Jenny Worthington, Mariana Bertani, Hong-Lin Chan, Bertran Gerrits & John F Timms. (2010) Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells - interplay of ErbB and IGF1 signalling through IGFBP3 regulation. BMC Cancer 10:1.
Crossref
Crossref
Sergio R. Ojeda, Alejandro Lomniczi & Ursula Sandau. (2010) Contribution of glial-neuronal interactions to the neuroendocrine control of female puberty. European Journal of Neuroscience 32:12, pages 2003-2010.
Crossref
Crossref
Ary Serpa Neto, Marcos Tobias-Machado, Marcelo Langer Wroclawski, Fernando Luiz Affonso Fonseca, Gabriel Kushiyama Teixeira, Rodrigo Dal Moro Amarante, Eric Roger Wroclawski & Auro Del Giglio. (2010)
HER-2/
neu
Expression in Prostate Adenocarcinoma: A Systematic Review and Meta-Analysis
. Journal of Urology 184:3, pages 842-850.
Crossref
Crossref
Sofi Forsberg & Ola Rollman. (2010) Re-epithelialization from human skin explant cultures is promoted by ligand-activated HER3 receptor. Journal of Dermatological Science 59:1, pages 7-15.
Crossref
Crossref
Connie G. Chiu, Hamid Masoudi, Samuel Leung, David K. Voduc, Blake Gilks, David G. Huntsman & Sam M. Wiseman. (2010) HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival. Annals of Surgery 251:6, pages 1107-1116.
Crossref
Crossref
Erika Iivanainen, Susanna Lauttia, Na Zhang, Denis Tvorogov, Jarmo Kulmala, Reidar Grenman, Petri Salven & Klaus Elenius. (2009) The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels. Microvascular Research 78:3, pages 278-285.
Crossref
Crossref
Melanie Spears & John M.S. Bartlett. (2012) Human Epidermal Growth Factor Receptor Dimerization Analysis in Breast Cancer Diagnosis. Molecular Diagnosis & Therapy 13:6, pages 359-365.
Crossref
Crossref
Erik Vernet, Emma Lundberg, Mikaela Friedman, Nicolò Rigamonti, Sandra Klausing, Per-Åke Nygren & Torbjörn Gräslund. (2009) Affibody-mediated retention of the epidermal growth factor receptor in the secretory compartments leads to inhibition of phosphorylation in the kinase domain. New Biotechnology 25:6, pages 417-423.
Crossref
Crossref
Nira Ben-Jonathan, Shenglin Chen, Joseph A. Dunckley, Christopher LaPensee & Sanjay Kansra. (2009) Estrogen Receptor-α Mediates the Epidermal Growth Factor-Stimulated Prolactin Expression and Release in Lactotrophs. Endocrinology 150:2, pages 795-802.
Crossref
Crossref
Ei. Terasawa & S.R. Ojeda. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
2035
2113
.
Alejandro Lomniczi & Sergio R. Ojeda. 2009. Astrocytes in (Patho)Physiology of the Nervous System. Astrocytes in (Patho)Physiology of the Nervous System
487
511
.
Y.-J. J. Chen, L. W. Role & D. A. Talmage. 2009. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
243
265
.
John W. Park, Richard M. Neve, Janos Szollosi & Christopher C. Benz. (2008) Unraveling the Biologic and Clinical Complexities of HER2. Clinical Breast Cancer 8:5, pages 392-401.
Crossref
Crossref
Daniel J. Barr, Anne G. Ostermeyer-Fay, Rachel A. Matundan & Deborah A. Brown. (2008) Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells. Journal of Cell Science 121:19, pages 3155-3166.
Crossref
Crossref
Marianela Perez-Torres, Blanca L. Valle, Nita J. Maihle, Lisandra Negron-Vega, Rene Nieves-Alicea & Elsa M. Cora. (2008) Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Experimental Cell Research 314:16, pages 2907-2918.
Crossref
Crossref
G Sithanandam & L M Anderson. (2008) The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Therapy 15:7, pages 413-448.
Crossref
Crossref
Jacqueline M. Lafky, Jason A. Wilken, Andre T. Baron & Nita J. Maihle. (2008) Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785:2, pages 232-265.
Crossref
Crossref
Bhaumik B. Patel & Adhip P. N. Majumdar. 2008. Pancreatic Cancer. Pancreatic Cancer
609
634
.
Floriana Morgillo, Maria Anna Bareschino, Roberto Bianco, Giampaolo Tortora & Fortunato Ciardiello. (2007) Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy. Differentiation 75:9, pages 788-799.
Crossref
Crossref
Mark R. Anderson, Rebecca Harrison, Paul A. Atherfold, Moray J. Campbell, S. Jane Darnton, Jolanta Obszynska & Janusz A.Z Jankowski. (2006) Met Receptor Signaling: A Key Effector in Esophageal Adenocarcinoma. Clinical Cancer Research 12:20, pages 5936-5943.
Crossref
Crossref
Jyoti Nautiyal. (2006) Emerging therapies in gastrointestinal cancers. World Journal of Gastroenterology 12:46, pages 7440.
Crossref
Crossref
Rodney C. P. Go, Rodney T. Perry, Howard Wiener, Susan S. Bassett, Deborah Blacker, Bernie Devlin & Robert A. Sweet. (2005) Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 139B:1, pages 28-32.
Crossref
Crossref
Kathleen M. Woods Ignatoski, Michele L. Dziubinski, Cheryl Ammerman & Stephen P. Ethier. (2005) Cooperative Interactions of HER-2, HPV-16 Oncoproteins in the Malignant Transformation of Human Mammary Epithelial Cells. Neoplasia 7:8, pages 788-798.
Crossref
Crossref
Michele De Laurentiis, Grazia Arpino, Erminia Massarelli, Angela Ruggiero, Chiara Carlomagno, Fortunato Ciardiello, Giampaolo Tortora, Diego D'Agostino, Francesca Caputo, Giuseppe Cancello, Emilia Montagna, Luca Malorni, Luigia Zinno, Rossella Lauria, Angelo Raffaele Bianco & Sabino De Placido. (2005) A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer. Clinical Cancer Research 11:13, pages 4741-4748.
Crossref
Crossref
Yi Peter Hu, Srinivas Venkateswarlu, Natalia Sergina, Gillian Howell, Patricia St. Clair, Lisa E. Humphrey, Wenhui Li, Jennie Hauser, Elizabeth Zborowska, James K.V. Willson & Michael G. Brattain. (2005) Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer Cells. Journal of Biological Chemistry 280:29, pages 27383-27392.
Crossref
Crossref
P.H. Rajjayabun, P.E. Keegan, J. Lunec & J.K. Mellon. (2005) erbB receptor expression patterns in human bladder cancer. Urology 66:1, pages 196-200.
Crossref
Crossref
Claire Varley, Gemma Hill, Stephanie Pellegrin, Nicola J. Shaw, Peter J. Selby, Ludwik K. Trejdosiewicz & Jennifer Southgate. (2005) Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro. Experimental Cell Research 306:1, pages 216-229.
Crossref
Crossref
Edward Htun van der Horst, Igor Weber & Axel Ullrich. (2005) Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: Novel heregulin/HER3-stimulated signaling pathway in glioma. International Journal of Cancer 113:5, pages 689-698.
Crossref
Crossref
Patrizia Casalini, Marilena V. Iorio, Enrico Galmozzi & Sylvie Ménard. (2004) Role of HER receptors family in development and differentiation. Journal of Cellular Physiology 200:3, pages 343-350.
Crossref
Crossref
Yuji Miyazaki, Yasuo Nakanishi & Yohki Hieda. (2004) Tissue interaction mediated by neuregulin-1 and ErbB receptors regulates epithelial morphogenesis of mouse embryonic submandibular gland. Developmental Dynamics 230:4, pages 591-596.
Crossref
Crossref
Wenle Xia, Lei-Hua Liu, Peter Ho & Neil L Spector. (2004) Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016. Oncogene 23:3, pages 646-653.
Crossref
Crossref
Farida Jhabvala-Romero, Adam Evans, Shuhua Guo, Michael Denton & Gail Mary Clinton. (2003) Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2. Oncogene 22:50, pages 8178-8186.
Crossref
Crossref
Joni L. Rutter, Nilanjan Chatterjee, Sholom Wacholder & Jeffrey Struewing. (2003) The HER2 I655V Polymorphism and Breast Cancer Risk in Ashkenazim. Epidemiology 14:6, pages 694-700.
Crossref
Crossref
Erika Iivanainen, Lassi Nelimarkka, Varpu Elenius, Satu-Maria Heikkinen, Teemu T. Junttila, Laura Sihombing, Maria Sundvall, Jorma A. Määttä, V. Jukka O. Laine, Seppo Ylä-Herttuala, Shigeki Higashiyama, Kari Alitalo & Klaus Elenius. (2003) Angiopoietin‐regulated recruitment of vascular smooth muscle cells by endothelial‐derived heparin binding EGF‐like growth factor. The FASEB Journal 17:12, pages 1609-1621.
Crossref
Crossref
G. Hudelist, C.F. Singer, M. Manavi, K. Pischinger, E. Kubista & K. Czerwenka. (2003) Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors. Breast Cancer Research and Treatment 80:3, pages 353-361.
Crossref
Crossref
DAVID C. LEE, SUSAN WOHLER SUNNARBORG, C. LEANN HINKLE, TIMOTHY J. MYERS, MARY STEVENSON, WILLIAM E. RUSSELL, BEVERLY J. CASTNER, MARY J. GERHART, RAYMOND J. PAXTON, ROY A. BLACK, AILEEN CHANG & LESLIE F. JACKSON. (2003) TACE/ADAM17 Processing of EGFR Ligands Indicates a Role as a Physiological Convertase. Annals of the New York Academy of Sciences 995:1, pages 22-38.
Crossref
Crossref
Yum L. Yip, Jiri Novotny, Michael Edwards & Robyn L. Ward. (2003) Structural analysis of the ErbB-2 receptor using monoclonal antibodies: Implications for receptor signalling. International Journal of Cancer 104:3, pages 303-309.
Crossref
Crossref
Stephen Hyland, Roger R Beerli, Carlos F BarbasIIIIII, Nancy E Hynes & Winfried Wels. (2003) Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor. Oncogene 22:10, pages 1557-1567.
Crossref
Crossref
Thomas Holbro, Gianluca Civenni & Nancy E. Hynes. 2003. The EGF Receptor Family. The EGF Receptor Family
103
114
.
Graham Carpenter. 2003. The EGF Receptor Family. The EGF Receptor Family
69
80
.
Thomas Dittmar, Anja Husemann, Yvonne Schewe, Jerzy‐Roch Nofer, Bernd Niggemann, Kurt S. Zänker & Burkhard H. Brandt. (2002) Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c‐erbB‐2 receptor via epidermal growth factor receptor. The FASEB Journal 16:13, pages 1-21.
Crossref
Crossref
Lily YenNaciba BenlimameZeng-Rong NieDingzhang XiaoTaiqi WangAla-Eddin Al MoustafaHiroyasu EsumiJulie Milanini, Nancy E. Hynes, Gilles Pages & Moulay A. Alaoui-Jamali. (2002) Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers. Molecular Biology of the Cell 13:11, pages 4029-4044.
Crossref
Crossref
Christoph UherekTorsten TonnBarbara UherekSven BeckerBarbara SchnierleHans-Georg KlingemannWinfried Wels. (2002) Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. Blood 100:4, pages 1265-1273.
Crossref
Crossref
David B Agus, Robert W Akita, William D Fox, Gail D Lewis, Brian Higgins, Paul I Pisacane, Julie A Lofgren, Charles Tindell, Douglas P Evans, Krista Maiese, Howard I Scher & Mark X Sliwkowski. (2002) Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. Cancer Cell 2:2, pages 127-137.
Crossref
Crossref
Jingwen Hou, Biao Li, Zhihui Yang, Nicole Fager & Mark Y. J. Ma. (2002) Functional Integrity of ErbB-4/-2 Tyrosine Kinase Receptor Complex in the Hypothalamus Is Required for Maintaining Normal Reproduction in Young Adult Female Rats. Endocrinology 143:5, pages 1901-1912.
Crossref
Crossref
W. Zhou & G. Carpenter. (2002) ErbB-4: a receptor tyrosine kinase. Inflammation Research 51:2, pages 91-101.
Crossref
Crossref
Srinivas Venkateswarlu, Dawn M Dawson, Patricia St Clair, Anjana Gupta, James KV Willson & Michael G Brattain. (2002) Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene 21:1, pages 78-86.
Crossref
Crossref
Sergio R. Ojeda & Ei Terasawa. 2002. Hormones, Brain and Behavior. Hormones, Brain and Behavior
589
659
.
Y. Lu, X. Zi, Y. Zhao, D. Mascarenhas & M. Pollak. (2001) Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin). JNCI Journal of the National Cancer Institute 93:24, pages 1852-1857.
Crossref
Crossref
Monilola A Olayioye. (2001) Intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Research 3:6.
Crossref
Crossref
Isabelle Hoffmann, Emmanuel Eugène, Xavier Nassif, Pierre-Olivier Couraud & Sandrine Bourdoulous. (2001) Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis. Journal of Cell Biology 155:1, pages 133-144.
Crossref
Crossref
Nicolas G Azios, Farida Jhabvala Romero, Michael C Denton, Joni K Doherty & Gail M Clinton. (2001) Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor. Oncogene 20:37, pages 5199-5209.
Crossref
Crossref
Stathis Meintanis, Dimitra Thomaidou, Kristjan R. Jessen, Rhona Mirsky & Rebecca Matsas. (2001) The neuron-glia signal ?-neuregulin promotes Schwann cell motility via the MAPK pathway. Glia 34:1, pages 39-51.
Crossref
Crossref
Isabel Mart�nez-Lacaci, Marta De Santis, Subha Kannan, Caterina Bianco, Nancy Kim, Brenda Wallace-Jones, Christian Wechselberger, Andreas D. Ebert & David S. Salomon. (2001) Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human Mammary epithelial cells. Journal of Cellular Physiology 186:2, pages 233-242.
Crossref
Crossref
Satoshi MATSUYAMA, Mieko NAKAMURA, Kumiko YONEZAWA, Terumasa SHIMADA, Fumihito OHASHI, Yasuhiko TAKAMORI & Kihei KUBO. (2001) Expression PAtterns of the erbB Subfamily mRNA in Canine Benign and Malignant Mammary Tumors.. Journal of Veterinary Medical Science 63:9, pages 949-954.
Crossref
Crossref
Stefan W. Stoll, Sanjay Kansra, Scott Peshick, David W. Fry, Wilbur R. Leopold, Jane F. Wiesen, Maria Sibilia, Tong Zhang, Zena Werb, Rik Derynck, Erwin F. Wagner & James T. Elder. (2001) Differential Utilization and Localization of ErbB Receptor Tyrosine Kinases in Skin Compared to Normal and Malignant Keratinocytes. Neoplasia 3:4, pages 339-350.
Crossref
Crossref
Wenli Zhou & Graham Carpenter. (2000) Heregulin-dependent Trafficking and Cleavage of ErbB-4. Journal of Biological Chemistry 275:44, pages 34737-34743.
Crossref
Crossref
Jun-ichi Okano, Irphan Gaslightwala, Morris J. Birnbaum, Anil K. Rustgi & Hiroshi Nakagawa. (2000) Akt/Protein Kinase B Isoforms Are Differentially Regulated by Epidermal Growth Factor Stimulation. Journal of Biological Chemistry 275:40, pages 30934-30942.
Crossref
Crossref
Richard M Neve, Hedwig Sutterlüty, Nicholas Pullen, Heidi A Lane, John M Daly, Wilhelm Krek & Nancy E Hynes. (2000) Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Oncogene 19:13, pages 1647-1656.
Crossref
Crossref
Sheila Zrihan-Licht, Yigong Fu, Jeffrey Settleman, Karin Schinkmann, Leslie Shaw, Iafa Keydar, Shalom Avraham & Hava Avraham. (2000) RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 19:10, pages 1318-1328.
Crossref
Crossref
Sylvie M�nard, Elda Tagliabue, Manuela Campiglio & Serenella M. Pupa. (2000) Role of HER2 gene overexpression in breast carcinoma. Journal of Cellular Physiology 182:2, pages 150-162.
Crossref
Crossref
Sung-Oh Kim, Jon C.D. Houtman, Jing Jiang, J. Michael Ruppert, Paul J. Bertics & Stuart J. Frank. (1999) Growth Hormone-induced Alteration in ErbB-2 Phosphorylation Status in 3T3-F442A Fibroblasts. Journal of Biological Chemistry 274:50, pages 36015-36024.
Crossref
Crossref
Sandra Won, Jutong Si, Marcie Colledge, Kodimangalam S. Ravichandran, Stanley C. Froehner & Lin Mei. (2002) Neuregulin-Increased Expression of Acetylcholine Receptorε-Subunit Gene Requires ErbB Interaction with Shc. Journal of Neurochemistry 73:6, pages 2358-2368.
Crossref
Crossref
Ying J. Ma, Diane F. Hill, Kimberly E. Creswick, Maria E. Costa, Anda Cornea, Mario N. Lioubin, Gregory D. Plowman & Sergio R. Ojeda. (1999) Neuregulins Signaling via a Glial erbB-2–erbB-4 Receptor Complex Contribute to the Neuroendocrine Control of Mammalian Sexual Development. The Journal of Neuroscience 19:22, pages 9913-9927.
Crossref
Crossref
Maria Eugenia Balañá, Ruth Lupu, Leticia Labriola, Eduardo H Charreau & Patricia V Elizalde. (1999) Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas. Oncogene 18:46, pages 6370-6379.
Crossref
Crossref
Burkhard H. Brandt, Antje Roetger, Thomas Dittmar, Gerd Nikolai, Matthes Seeling, Anja Merschjann, Jerzy‐Roch Nofer, Gunda Dehmer‐Möller, Ralf Junker, Gerd Assmann & Kurt S. Zaenker. (1999) c‐erbB‐2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. The FASEB Journal 13:14, pages 1939-1949.
Crossref
Crossref
K Wiechen, S Karaaslan, A Turzynski & M Dietel. (1999) Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells. British Journal of Cancer 81:5, pages 790-795.
Crossref
Crossref
Claudio Ceccarelli, Donatella Santini, Michela Gamberini, Mario Taffurelli, Pasquale Chieco, Simonetta Piana, Stefano Pileri & Domenico Marrano. (1999) Immunohistochemical expression of internal and external ErbB‐2 domains in invasive breast cancer. Breast Cancer Research and Treatment 58:2, pages 107-114.
Crossref
Crossref
Kai Wiechen, Selma Karaaslan & Manfred Dietel. (1999)
Involvement of the c‐
erb
B‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells
. International Journal of Cancer 83:3, pages 409-414.
Crossref
Crossref
Zuleima Aguilar, Robert W Akita, Richard S Finn, B Lillian Ramos, Mark D Pegram, Fairooz F Kabbinavar, Richard J Pietras, Paul Pisacane, Mark X Sliwkowski & Dennis J Slamon. (1999) Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene 18:44, pages 6050-6062.
Crossref
Crossref
Sergio R. Ojeda & Ying J. Ma. (1999) Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: Facilitatory effects of gonadal steroids. Journal of Neurobiology 40:4, pages 528-540.
Crossref
Crossref
Yoon S. Cho-Chung, Serge Beaucage, Victor Marquez, Leonard Neckers & Paul F. Torrence. (1999) Abstracts from the Third Annual NIH Symposium on Therapeutic Oligonucleotides. Antisense and Nucleic Acid Drug Development 9:4, pages 359-431.
Crossref
Crossref
Raghda Asslan, Anne Pradines, Corélia Pratx, Cuider Allal, Gilles Favre & Francis Le Gaillard. (1999) Epidermal Growth Factor Stimulates 3-Hydroxy-3-Methylglutaryl-coenzyme A Reductase Expression via the ErbB-2 Pathway in Human Breast Adenocarcinoma Cells. Biochemical and Biophysical Research Communications 260:3, pages 699-706.
Crossref
Crossref
Manuela Campiglio, Suhad Ali, Piotr G. Knyazev & Axel Ullrich. (1999) Characteristics of EGFR family-mediated HRG signals in human ovarian cancer. Journal of Cellular Biochemistry 73:4, pages 522-532.
Crossref
Crossref
Péter Nagy, Attila Jenei, Achim K. Kirsch, János Szöllősi, Sándor Damjanovich & Thomas M. Jovin. (1999) Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy. Journal of Cell Science 112:11, pages 1733-1741.
Crossref
Crossref
Nadeem Moghal & Paul W Sternberg. (1999) Multiple positive and negative regulators of signaling by the EGF-receptor. Current Opinion in Cell Biology 11:2, pages 190-196.
Crossref
Crossref
Caterina Bianco, Subha Kannan, Marta De Santis, Masaharu Seno, Careen K. Tang, Isabel Martinez-Lacaci, Nancy Kim, Brenda Wallace-Jones, Marc E. Lippman, Andreas D. Ebert, Christian Wechselberger & David S. Salomon. (1999) Cripto-1 Indirectly Stimulates the Tyrosine Phosphorylation oferb B-4 through a Novel Receptor. Journal of Biological Chemistry 274:13, pages 8624-8629.
Crossref
Crossref
Alexander M. Castellino & Moses V. Chao. (1999) Differential Association of Phosphatidylinositol-5-Phosphate 4-Kinase with the EGF/ErbB Family of Receptors. Cellular Signalling 11:3, pages 171-177.
Crossref
Crossref
J Kurebayashi, T Otsuki, C K Tang, M Kurosumi, S Yamamoto, K Tanaka, M Mochizuki, H Nakamura & H Soono. (1999) Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6. British Journal of Cancer 79:5-6, pages 707-717.
Crossref
Crossref
Maryanne McClellan, Paul Kievit, Nelly Auersperg & Karin Rodland. (1999) Regulation of Proliferation and Apoptosis by Epidermal Growth Factor and Protein Kinase C in Human Ovarian Surface Epithelial Cells. Experimental Cell Research 246:2, pages 471-479.
Crossref
Crossref
Isabel Martinez-Lacaci, Caterina Bianco, Marta De Santis & David S. Salomon. 1999. Breast Cancer. Breast Cancer
31
57
.
Sabino De Placido, Chiara Carlomagno, Michelino De Laurentiis & Angelo Raffaele Bianco. (1998) c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients. Breast Cancer Research and Treatment 52:1-3, pages 55-64.
Crossref
Crossref
Ulf Vogt, Krzysztof Bielawski, Claus M Schlotter, Ulrich Bosse, Bogdan Falkiewicz & Anna J Podhajska. (1998) Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer1Published in conjunction with A Wisconsin Gathering Honoring Waclaw Szybalski on the occasion of his 75th year and 20 years of Editorship-in-Chief of Gene, 10–11 August, 1997, University of Wisconsin, Madison, WI, USA.1. Gene 223:1-2, pages 375-380.
Crossref
Crossref
Jon E. Grim, Gene P. Siegal, Ronald D. Alvarez & David T. Curiel. (1998) Intracellular Expression of the Anti-erbB-2 sFv N29 Fails to Accomplish Efficient Target Modulation. Biochemical and Biophysical Research Communications 250:3, pages 699-703.
Crossref
Crossref
Stefan Britsch, Li Li, Susanne Kirchhoff, Franz Theuring, Volker Brinkmann, Carmen Birchmeier & Dieter Riethmacher. (1998) The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes & Development 12:12, pages 1825-1836.
Crossref
Crossref
Joo-Yeon Yoo & Anne W Hamburger. (1998) Changes in heregulin β1 (HRGβ1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line. Molecular and Cellular Endocrinology 138:1-2, pages 163-171.
Crossref
Crossref
Juan A. Velasco, Esperanza Feijoó, Matías A. Avila & Vicente Notario. (1998) Secretion of neu differentiation factor–like polypeptides bycph-transformed fibroblasts: Cloning and characterization of Syrian hamster neuregulin cDNAs. Molecular Carcinogenesis 21:3, pages 156-163.
Crossref
Crossref
Roger R. Beerli, Diana Graus-Porta & Nancy E. Hynes. 1998. Intrabodies. Intrabodies
61
74
.
Sabino De Placido, Chiara Carlomagno, Michelino De Laurentiis & Angelo Raffaele Bianco. 1998. Prognostic variables in node-negative and node-positive breast cancer. Prognostic variables in node-negative and node-positive breast cancer
145
154
.
Renee Emkey & C. Ronald Kahn. (1997) Cross-talk between Phorbol Ester-mediated Signaling and Tyrosine Kinase Proto-oncogenes. Journal of Biological Chemistry 272:49, pages 31182-31189.
Crossref
Crossref
Renee Emkey & C. Ronald Kahn. (1997) Cross-talk between Phorbol Ester-mediated Signaling and Tyrosine Kinase Proto-oncogenes. Journal of Biological Chemistry 272:49, pages 31172-31181.
Crossref
Crossref
Claudia Rosenbaum, Saikumar Karyala, Mark A. Marchionni, Haesun A. Kim, Alexei L. Krasnoselsky, Beth Happel, Indu Isaacs, Robert Brackenbury & Nancy Ratner. (1997) Schwann Cells Express NDF and SMDF/n-ARIA mRNAs, Secrete Neuregulin, and Show Constitutive Activation of erbB3 Receptors: Evidence for a Neuregulin Autocrine Loop. Experimental Neurology 148:2, pages 604-615.
Crossref
Crossref
Rita Falcioni, Annalisa Antonini, Paola Nisticò, Stefania Di Stefano, Marco Crescenzi, Pier Giorgio Natali & Ada Sacchi. (1997) α6β4 and α6β1 Integrins Associate with ErbB-2 in Human Carcinoma Cell Lines. Experimental Cell Research 236:1, pages 76-85.
Crossref
Crossref
R.L. Ward, N.J. Hawkins & G.M. Smith. (1997) Unconjugated antibodies for cancer therapy: lessons from the clinic. Cancer Treatment Reviews 23:5-6, pages 305-319.
Crossref
Crossref
Han Chang, David J. Riese II, Walter Gilbert, David F. Stern & U. J. McMahan. (1997) Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 387:6632, pages 509-512.
Crossref
Crossref
Sheila Zrihan-Licht, Jinkyu Lim, Iafa Keydar, Mark X. Sliwkowski, Jerome E. Groopman & Hava Avraham. (1997) Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells. Journal of Biological Chemistry 272:3, pages 1856-1863.
Crossref
Crossref
Masashi Yamada, Toshihiko Ikeuchi & Hiroshi Hatanaka. (1997) The neurotrophic action and signalling of epidermal growth factor. Progress in Neurobiology 51:1, pages 19-37.
Crossref
Crossref
David M. Reese & Dennis J. Slamon. (2009)
HER‐2/
neu
Signal Transduction in Human Breast and Ovarian Cancer
. STEM CELLS 15:1, pages 1-8.
Crossref
Crossref
David J. RieseIIII, Edward D. Kim, Klaus Elenius, Sharon Buckley, Michael Klagsbrun, Gregory D. Plowman & David F. Stern. (1996) The Epidermal Growth Factor Receptor Couples Transforming Growth Factor-α, Heparin-binding Epidermal Growth Factor-like Factor, and Amphiregulin to Neu, ErbB-3, and ErbB-4. Journal of Biological Chemistry 271:33, pages 20047-20052.
Crossref
Crossref
James R. Florini, Derina S. Samuel, Daina Z. Ewton, Cassandra Kirk & Robert M. Sklar. (1996) Stimulation of Myogenic Differentiation by a Neuregulin, Glial Growth Factor 2. Journal of Biological Chemistry 271:22, pages 12699-12702.
Crossref
Crossref
Nancy E. Hynes. (1996) ErbB2 activation and signal transduction in normal and malignant mammary cells. Journal of Mammary Gland Biology and Neoplasia 1:2, pages 199-206.
Crossref
Crossref
Roger R. Beerli & Nancy E. Hynes. (1996) Epidermal Growth Factor-related Peptides Activate Distinct Subsets of ErbB Receptors and Differ in Their Biological Activities. Journal of Biological Chemistry 271:11, pages 6071-6076.
Crossref
Crossref